Calidi Biotherapeutics Secures Series A Investments to Advance Manufacturing
SAN DIEGO–(BUSINESS WIRE)–Calidi Biotherapeutics, Inc., a clinical‐stage immuno-oncology company at the forefront of cell-based oncolytic virus immunotherapies for cancer, today announced Series A investments from two South Korean firms to…